News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Rumor: Shire Mulls Over A $4 Billion Bid For U.S.-Based NPS Pharmaceuticals, Inc. (NPSP)


5/30/2014 2:55:40 PM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Seeking to secure its own independence as M&A activity — whether real or rumoured — continues to convulse the pharma sector, Britain’s Shire is believed to be considering a bid for New Jersey-based NPS Pharmaceuticals, a rare disease specialist. According to usually well informed sources, Shire has been working quietly with advisers and held internal discussions about a potential cash offer for NPS, valuing the US business at just over $4bn. That would imply a bid pitched at around $40 a share,compared with NPS’s $27.50 market quote on Nasdaq on Friday.

Help employers find you! Check out all the jobs and post your resume.

Read at Financial Times
Read at Reuters
Read at News Release
Read at Nasdaq


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES